Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression. [electronic resource]
Producer: 20060112Description: 202-12 p. digitalISSN:- 0163-5581
- Apoptosis -- drug effects
- Blotting, Western
- Caspase 3
- Caspases -- metabolism
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Curcumin -- pharmacology
- Cyclooxygenase 1 -- drug effects
- Cyclooxygenase 2 -- drug effects
- Cyclooxygenase 2 Inhibitors -- pharmacology
- Flow Cytometry
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Plant Extracts -- pharmacology
- Prostatic Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.